SNSS stock forecast
Our latest prediction for Sunesis Pharmaceuticals, Inc.'s stock price was made on the July 15, 2019 when the stock price was at 0.86$.
In the short term (2weeks), SNSS's stock price should outperform the market by 8.07%. During that period the price should oscillate between -11.54% and +24.95%.
In the medium term (3months), SNSS's stock price should outperform the market by 14.20%. During that period the price should oscillate between -23.38% and +66.46%.Get email alerts
About Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firms activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.64$ per share.
The book value per share is -0.30$
Three months stock forecastJuly 15, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|